Riskpilot← Back to searchSign inGet full accessF&S Sundhed & Behandling ApS
APSActiveCVR 37921483Strandkærvej 87B, st.Physiotherapy activities · NACE 8695Est. 20161 employeesfogs.dk
Revenue 2024
DKK -18K
-68% vs 2023
EBITDA margin
100.0%
+68% vs 2023
Equity ratio
-319519.4%
Financial strength
Net profit 2024
DKK 88K
+5971% vs 2023
| Revenue | DKK -18K | -68% |
| EBITDA | DKK -18K | +68% |
| Net profit | DKK 88K | +5971% |
| Total assets | DKK 98 | -91% |
| Equity | DKK -313K | +22% |
| Employees | 1 | — |
Legal name
F&S Sundhed & Behandling ApS
CVR number
37921483
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
10. august 2016
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør.
Company purpose
Selskabets formål er at fungere som hovedorganisation for tilknyttede virksomheder, der udøver fysioterapi og sundhedsrelaterede aktiviteter samt dermed beslægtet virksomhed.
Address
Strandkærvej 87B, st.
Website
fogs.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 61 | -328 | 4 | -58 | -18 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 61 | -328 | 4 | -58 | -18 |
| Depreciation & amort. | -4 | -3 | -0 | -0 | -0 |
| EBIT | 58 | -330 | 4 | -58 | -18 |
| Net financials | -9 | -14 | -199 | 60 | 107 |
| Profit before tax | 49 | -344 | -195 | 1 | 88 |
| Tax | 11 | -1 | -0 | -0 | -0 |
| Net profit | 38 | -344 | -195 | 1 | 88 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 462 | 384 | 58 | 1 | 0 |
| Equity | 136 | -208 | -403 | -402 | -313 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 325 | 592 | 461 | 403 | 313 |
| Total debt | 325 | 592 | 461 | 403 | 313 |
EBITDA margin
-1840800.0%
This company
15.8%
Market median
-11650733% vs market
20202024
Equity ratio
-319519.4%
This company
38.2%
Market median
-836538% vs market
20202024
Return on equity
8839200.0%
This company
18.4%
Market median
+48039030% vs market
20202024
Net profit margin
8839200.0%
This company
8.1%
Market median
+109125826% vs market
20202024
Asset turnover
-187.84×
This company
1.12×
Market median
-16871% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
LS Chief Executive Officer | Chief Executive Officer | 2019 – 2025 |
DC Management | Management | 2016 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Deputy Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (6) | ||
| Board of Directors | 2016 – 2019 | |
| Deputy Chairman | 2020 – 2025 | |
| Chairman | 2016 – 2017 | |
| Board of Directors | 2016 – 2019 | |
| Chairman | 2020 – 2025 | |
| Board of Directors | 2016 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AUTORISERET FYSIOTERAPEUT MICHAEL CHRISTENSEN ApSF & S Skanderborg Holding ApSF&S Fitness- & Sundhedshuse ApS
F&S Sundhed & Behandling ApS (this company)Board members of F&S Sundhed & Behandling ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Skytte Nielsen | Chief Executive Officer | 0 companies |
| Anders Rørbech Steffensen | Chief Executive Officer | 0 companies |
| Dorte Christina Alhed Rosendahl | Management | 0 companies |
| Lars Bo Kirschbaum Berg | Board of Directors | 0 companies |
| Johnny Michael Boilesen | Deputy Chairman | 0 companies |
| Erik Jakobsgaard Bro | Chairman | 0 companies |
| Niels Rosendahl | Board of Directors | 0 companies |
| Michael Christensen | Chairman | 0 companies |
| Niels Andreas Paulsen | Chairman | 0 companies |
| Daniel Staun Lademann | Board of Directors | 0 companies |
| Michael Seiger Kristiansen | Deputy Chairman | 0 companies |
| Ole Meyer | Board of Directors | 0 companies |
| Dennis Petersen | Board of Directors | 0 companies |